Veterinary teams across the UK are being invited to contribute anonymised clinical case studies to help build a broader evidence base around the use of faecal calprotectin testing in dogs and cats with inflammatory gastrointestinal disease. Information on case study submission can be found here.
Faecal calprotectin is already well established in human medicine as a non-invasive marker of intestinal inflammation and is increasingly being adopted in veterinary practice to support diagnostic decision-making and treatment monitoring. A validation study conducted at the University of Bristol has demonstrated that the GIQuest faecal calprotectin test can reliably distinguish dogs and cats with inflammatory enteropathy from healthy controls, with high sensitivity and specificity.
GIQuest is a patient-side lateral flow faecal calprotectin test, helping to guide next steps in dogs and cats with chronic GI conditions, including chronic enteropathy (CE; previously IBD), food responsive enteropathy (FRE) and GI side-effects associated with NSAID use.
Lucy Williams MRCVS, from Carus Animal Health, says, “Individual case experiences often highlight nuances that don’t always come through in formal studies. Bringing these together can help illustrate how faecal calprotectin testing is being applied in different clinical scenarios, from refining diagnostic pathways to supporting monitoring and owner communication. By sharing practical insights from everyday cases, the profession can collectively build confidence around when and how this tool is most useful in practice.”
Case studies can be submitted by both veterinary surgeons and veterinary nurses and may include, but are not limited to: dogs or cats with chronic or recurrent GI signs, suspected inflammatory enteropathies, monitoring response to dietary or treatment trials or identification of GI inflammation in patients receiving long term oral NSAIDs.
As a thank you for taking part, a number of incentives are available.* The five strongest case study submissions will each receive a £100 gift card, and the first 20 eligible entries will receive free access to a GI-focused CPD course with The Webinar Vet.
In addition, entries submitted before 31 January will be entered into a draw to win a delegate ticket to SPVS Congress (worth £675). Congress takes place in Birmingham on 26–27 February. This incentive is open to veterinary surgeons who have not previously attended or registered for SPVS Congress.
The case study initiative will close on 1st March. Submission guidelines and further details can be found here. Case studies should be submitted by email to lucy.williams@carusanimalhealth.com
*Terms and conditions apply and are available here.
To find out more, visit https://carusanimalhealth.com/giquest or contact Carus Animal Health at info@carusanimalhealth.com
Press contact: Katy Ellison, katy@companionconsultancy.com, Tel 07596 217372.
About Carus Animal Health
Carus Animal Health was established in 2017 with support from Kyoritsu Seiyaku, Japan’s largest distributor of animal health products. Focused on finding unique solutions to challenges across companion animal, farm animal, and aquaculture sectors, Carus works in partnership with academia and early-stage innovative companies to bring new diagnostics and treatments to the veterinary market. The company is committed to supporting sustainable animal health, including investment in alternatives to antibiotics and point-of-care diagnostics that enhance clinical decision-making and patient care. GIQuest is the company’s first point-of-care diagnostic test.
Leave a Reply